Smith & Nephew SNATS Retained Earnings (Accumulated Deficit) 2010-2024 | SNN
Smith & Nephew SNATS retained earnings (accumulated deficit) from 2010 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
- Smith & Nephew SNATS retained earnings (accumulated deficit) for the quarter ending December 31, 2024 were $5.018B, a 2.09% decline year-over-year.
- Smith & Nephew SNATS retained earnings (accumulated deficit) for 2024 were $5.018B, a 2.28% increase from 2023.
- Smith & Nephew SNATS retained earnings (accumulated deficit) for 2023 were $4.906B, a 2.39% decline from 2022.
- Smith & Nephew SNATS retained earnings (accumulated deficit) for 2022 were $5.026B, a 3.81% decline from 2021.
| Smith & Nephew SNATS Annual Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2024 | $5,018 |
| 2023 | $4,906 |
| 2022 | $5,026 |
| 2021 | $5,225 |
| 2020 | $4,958 |
| 2019 | $4,849 |
| 2018 | $4,625 |
| 2017 | $4,329 |
| 2016 | $3,970 |
| 2015 | $3,731 |
| 2014 | $3,650 |
| 2013 | $3,520 |
| 2012 | $3,817 |
| 2011 | $3,258 |
| 2010 | $2,848 |
| 2009 | $2,338 |
| Smith & Nephew SNATS Quarterly Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2024-12-31 | $5,018 |
| 2023-12-31 | $4,906 |
| 2023-06-30 | $4,963 |
| 2022-12-31 | $5,026 |
| 2022-06-30 | $5,125 |
| 2021-12-31 | $5,225 |
| 2021-06-30 | $4,985 |
| 2020-12-31 | $4,958 |
| 2020-06-30 | $4,743 |
| 2019-12-31 | $4,849 |
| 2019-06-30 | $4,708 |
| 2018-12-31 | $4,625 |
| 2018-06-30 | $4,358 |
| 2017-12-31 | $4,329 |
| 2017-06-30 | $3,956 |
| 2016-12-31 | $3,970 |
| 2015-12-31 | $3,731 |
| 2015-06-30 | $3,713 |
| 2014-12-31 | $3,650 |
| 2014-09-30 | $3,559 |
| 2014-06-30 | $3,590 |
| 2014-03-31 | $3,668 |
| 2013-12-31 | $3,520 |
| 2013-09-30 | $3,443 |
| 2013-06-30 | $3,872 |
| 2013-03-31 | $3,944 |
| 2012-12-31 | $3,817 |
| 2012-09-30 | $3,625 |
| 2012-06-30 | $3,615 |
| 2012-03-31 | $3,454 |
| 2011-12-31 | $3,258 |
| 2011-09-30 | $3,227 |
| 2011-06-30 | $3,092 |
| 2011-03-31 | $3,184 |
| 2010-12-31 | $2,848 |
| 2010-09-30 | $2,683 |
| 2010-06-30 | $2,508 |
| 2010-03-31 | $2,431 |
| 2009-12-31 | $2,338 |
| 2009-09-30 | $2,196 |
| 2009-06-30 | $2,106 |
| 2009-03-31 | $1,959 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $12.846B | $5.810B |
| Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physicianadvantage and real patient benefits. A continuous process of supplying new and innovative products is supported by substantial R&D investment todeliver new levels of healing to patients throughout the world | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $228.771B | 27.51 |
| Boston Scientific (BSX) | United States | $153.093B | 38.33 |
| Stryker (SYK) | United States | $149.084B | 31.17 |
| EssilorLuxottica (ESLOY) | France | $130.144B | 0.00 |
| Medtronic (MDT) | Ireland | $114.429B | 16.22 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.231B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.710B | 24.95 |
| ResMed (RMD) | United States | $36.952B | 27.75 |
| GE HealthCare Technologies (GEHC) | United States | $34.062B | 16.17 |
| Agilent Technologies (A) | United States | $32.082B | 20.92 |
| Terumo (TRUMY) | Japan | $24.207B | 31.44 |
| Koninklijke Philips (PHG) | Netherlands | $23.216B | 16.29 |
| Insulet (PODD) | United States | $20.408B | 80.11 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.604B | 11.95 |
| Baxter (BAX) | United States | $14.497B | 10.82 |
| Demant (WILYY) | Denmark | $8.633B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.731B | 23.42 |
| Lantheus Holdings (LNTH) | United States | $5.622B | 14.18 |
| Perrigo (PRGO) | Ireland | $3.719B | 9.43 |
| Prestige Consumer Healthcare (PBH) | United States | $3.714B | 16.59 |
| Haemonetics (HAE) | United States | $3.585B | 16.33 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.358B | 27.90 |
| ICU Medical (ICUI) | United States | $3.113B | 22.96 |
| QuidelOrtho (QDEL) | United States | $1.890B | 13.00 |
| LeMaitre Vascular (LMAT) | United States | $1.858B | 41.53 |
| AtriCure (ATRC) | United States | $1.512B | 0.00 |
| Acuren (TIC) | United States | $1.407B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.245B | 28.00 |
| Phibro Animal Health (PAHC) | United States | $1.239B | 15.83 |
| AdaptHealth (AHCO) | United States | $1.205B | 12.23 |
| Neogen (NEOG) | United States | $1.079B | 13.81 |
| BioLife Solutions (BLFS) | United States | $0.994B | 0.00 |
| InMode (INMD) | Israel | $0.901B | 9.08 |
| Kestra Medical Technologies (KMTS) | United States | $0.836B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.670B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.660B | 0.00 |
| Owens & Minor (OMI) | United States | $0.600B | 4.98 |
| Evolus (EOLS) | United States | $0.598B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.597B | 0.00 |
| CeriBell (CBLL) | United States | $0.569B | 0.00 |
| Valneva SE (VALN) | France | $0.549B | 0.00 |
| Surmodics (SRDX) | United States | $0.448B | 0.00 |
| SNDL (SNDL) | Canada | $0.397B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.328B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.318B | 11.71 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.304B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.285B | 0.00 |
| Quanterix (QTRX) | United States | $0.274B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.262B | 22.07 |
| Cresco Labs (CRLBF) | United States | $0.258B | 0.00 |
| Cerus (CERS) | United States | $0.258B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.252B | 74.83 |
| ZimVie (ZIMV) | United States | $0.246B | 11.19 |
| Sanara MedTech (SMTI) | United States | $0.242B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.233B | 0.00 |
| Brainsway (BWAY) | Israel | $0.231B | 61.00 |
| Biote (BTMD) | United States | $0.216B | 6.06 |
| Omeros (OMER) | United States | $0.212B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.200B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.199B | 0.00 |
| Organigram Global (OGI) | Canada | $0.192B | 0.00 |
| High Tide (HITI) | Canada | $0.188B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.182B | 14.80 |
| TriSalus Life Sciences (TLSI) | United States | $0.179B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.155B | 0.00 |
| Exagen (XGN) | United States | $0.144B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.124B | 15.25 |
| TerrAscend (TSNDF) | Canada | $0.107B | 0.00 |
| Jin Medical (ZJYL) | China | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.099B | 12.80 |
| MacroGenics (MGNX) | United States | $0.094B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.087B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.085B | 0.00 |
| Veru (VERU) | United States | $0.085B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.080B | 0.00 |
| Apyx Medical (APYX) | United States | $0.077B | 0.00 |
| Zynex (ZYXI) | United States | $0.069B | 0.00 |
| Agape ATP (ATPC) | $0.069B | 0.00 | |
| InterCure (INCR) | Israel | $0.068B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.064B | 0.00 |
| ImmuCell (ICCC) | United States | $0.057B | 0.00 |
| United-Guardian (UG) | United States | $0.042B | 14.41 |
| Modular Medical (MODD) | United States | $0.038B | 0.00 |
| Nephros (NEPH) | United States | $0.037B | 50.43 |
| Rockwell Medical (RMTI) | United States | $0.037B | 0.00 |
| Safety Shot (SHOT) | United States | $0.032B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.024B | 0.00 |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| INLIF (INLF) | $0.015B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.013B | 0.00 |
| Senestech (SNES) | United States | $0.011B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |